Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Change in Account Payables: 2013-2019

Historic Change in Account Payables for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to $260,000.

  • Soleno Therapeutics' Change in Account Payables rose 171.63% to $260,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.1 million, marking a year-over-year increase of 326.10%. This contributed to the annual value of $5.7 million for FY2024, which is 313.41% up from last year.
  • According to the latest figures from Q4 2019, Soleno Therapeutics' Change in Account Payables is $260,000, which was up 5,300.00% from -$5,000 recorded in Q3 2019.
  • Soleno Therapeutics' Change in Account Payables' 5-year high stood at $627,000 during Q1 2016, with a 5-year trough of -$549,000 in Q2 2016.
  • Its 3-year average for Change in Account Payables is $125,083, with a median of $211,500 in 2017.
  • Per our database at Business Quant, Soleno Therapeutics' Change in Account Payables crashed by 785.37% in 2018 and then surged by 890.16% in 2019.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Change in Account Payables stood at -$330,055 in 2015, then dropped by 25.08% to -$412,828 in 2016, then spiked by 90.07% to -$41,000 in 2017, then slumped by 785.37% to -$363,000 in 2018, then soared by 171.63% to $260,000 in 2019.
  • Its last three reported values are $260,000 in Q4 2019, -$5,000 for Q3 2019, and $482,000 during Q2 2019.